Blog

Understanding the HPAPI sector

Recently, Konstantinos Apostolou, R&D senior manager at our Athens Development facility, was featured in European Pharmaceutical Manufacturer, where he explored the rapid rise of highly potent active pharmaceutical ingredients (HPAPIs). The market is valued at $185.5 billion in 2024 and […]

Ensuring Sterility: A Team Effort 

Annex 1 to EU GMP for sterile products came into effect in 2023, and while technically it is for the EU, in practice it has rapidly become a worldwide standard. It has brought in a number of additional formal requirements […]

Subscribe to our newsletter!

Get notified on our latest news.